Adherence Assessment Using Medication Weight in a Phase IIb Clinical Trial of Difluoromethylornithine for the Chemoprevention of Skin Cancer

Objective: Adherence is a common and essential measurement in clinical trials. This study evaluates the association between participant self-reported study diary records and the weight of the medication vessel at each study visit, in the setting of a phase IIb topical chemoprevention trial. Methods:...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer epidemiology, biomarkers & prevention biomarkers & prevention, 2005-11, Vol.14 (11), p.2579-2583
Hauptverfasser:	HESS, Lisa M, SABODA, Kathylynn, MALONE, Daniel C, SALASCHE, Stuart, WARNEKE, James, ALBERTS, David S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adherence Administration, Topical Adult Aged Aged, 80 and over Antineoplastic agents Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use Biological and medical sciences Chemoprevention Chemotherapy compliance DFMO Eflornithine - administration & dosage Eflornithine - therapeutic use Female Glucocorticoids - administration & dosage Glucocorticoids - therapeutic use Humans Male Medical sciences methodology Middle Aged Patient Compliance Pharmacology. Drug treatments Placebos Skin Neoplasms - prevention & control topical agents Triamcinolone - administration & dosage Triamcinolone - therapeutic use Truth Disclosure Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!